Rensselaer Polytechnic Institute in Troy signed an agreement with a South Korean organization that represents small-to-medium ...
The use of nanoparticles to improve feed efficiency and poultry health has significant potential to reduce the spread of ...
The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...
This study presents a comprehensive approach for assessing multiple quality attributes of antibody-oligonucleotide conjugates ...
The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...
AI startup Manus’ deal with Meta scrutinized over tech control restrictions | Dawu County court discovers AI watermark on fake evidence and issues formal reprimand | Hainan launches "closed customs ...
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
CDK2-mediated TBK1 degradation via Dtx4 represents a previously unrecognized regulatory mechanism that modulates antiviral immunity in fish.
The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback